share_log

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(14.73%),David E. Goel(14.73%)

Adaptimmune Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Matrix Capital Management Company LP(14.73%),David E. Goel(14.73%)

美股SEC公告 ·  2024/11/13 09:08
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息